By Fineline Cube 
IVD Medical Holding Limited (HKG: 1931) disclosed that it will purchase 1,848,496,429 shares of GoFintech Quantum Innovation Limited (HKG: 0290), equating to roughly 20.31 % of GoFintech’s total issued share capital. The transaction will be paid via consideration shares issued at HK$9.69 per share, bringing the total consideration to HK$3,142,443,930.
Deal Structure
- Acquisition price – HK$9.69 per share, totaling HK$3.14 billion.
- Share count – 1.85 m shares, 20.31 % of GoFintech’s issued capital.
- Payment method – Allotment and issuance of consideration shares under the general mandate.
- Post‑closing status – IVD Medical will become a major shareholder of GoFintech.
Strategic Rationale
- Real‑World Asset (RWA) strategy – The deal dovetails with IVD Medical’s ongoing RWA exchange strategy, positioning the company for deeper integration across the financial‑services ecosystem.
- Synergy potential – GoFintech’s robust presence in the financial services sector offers immediate complementary capabilities, creating cross‑sell and technology‑integration opportunities.
- Capital value – The acquisition is expected to unlock significant value for both shareholders and the broader market, reinforcing IVD Medical’s growth trajectory.
GoFintech Snapshot
- Industry focus – Investment holding company with strong financial‑services exposure.
- Current portfolio – Includes fintech platforms, asset‑management tools, and digital banking solutions.
Next Steps
- Regulatory review – The transaction is subject to approval by the Hong Kong Securities and Futures Commission and relevant corporate governance bodies.
- Integration planning – IVD Medical will commence detailed integration planning to maximize synergies and accelerate RWA deployment.-Fineline Info & Tech